相似文献
1
Heated Intraperitoneal Chemotherapy in the Management of Advanced Ovarian Cancer.
Cancers (Basel). 2018 Sep 1;10(9):296. doi: 10.3390/cancers10090296.
2
Heated IntraPEritoneal Chemotherapy (HIPEC) for Patients With Recurrent Ovarian Cancer: A Systematic Literature Review.
Int J Gynecol Cancer. 2016 May;26(4):661-70. doi: 10.1097/IGC.0000000000000664.
3
Treatment of peritoneal carcinomatosis from ovarian cancer by surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
Minerva Chir. 2014 Feb;69(1):27-35.
4
Cytoreduction (Peritonectomy Procedures) Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Advanced Ovarian Cancer: Retrospective Italian Multicenter Observational Study of 511 Cases.
Ann Surg Oncol. 2017 Apr;24(4):914-922. doi: 10.1245/s10434-016-5686-1. Epub 2016 Nov 28.
5
Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study.
JMIR Res Protoc. 2017 Jul 13;6(7):e136. doi: 10.2196/resprot.7790.
6
Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy in the Management of Colorectal Peritoneal Metastasis.
Surg Clin North Am. 2017 Jun;97(3):671-682. doi: 10.1016/j.suc.2017.01.013.
7
Intraperitoneal chemotherapy hyperthermia (HIPEC) for peritoneal carcinomatosis of ovarian cancer origin by fluid and CO2 recirculation using the closed abdomen technique (PRS-1.0 Combat): A clinical pilot study.
Int J Hyperthermia. 2016 Aug;32(5):488-95. doi: 10.3109/02656736.2016.1152515. Epub 2016 Apr 7.
8
Treatment of microscopic disease with hyperthermic intraoperative intraperitoneal chemotherapy after complete cytoreduction improves disease-free survival in patients with stage IIIC/IV ovarian cancer.
Ann Surg Oncol. 2014 Jul;21(7):2383-9. doi: 10.1245/s10434-014-3599-4. Epub 2014 Mar 6.
9
HIPEC ROC I: a phase I study of cisplatin administered as hyperthermic intraoperative intraperitoneal chemoperfusion followed by postoperative intravenous platinum-based chemotherapy in patients with platinum-sensitive recurrent epithelial ovarian cancer.
Int J Cancer. 2015 Feb 1;136(3):699-708. doi: 10.1002/ijc.29011. Epub 2014 Jun 17.
10
Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: a prospective study.
J Gynecol Oncol. 2019 Jul;30(4):e59. doi: 10.3802/jgo.2019.30.e59. Epub 2019 Mar 1.
引用本文的文献
1
Comparative Sensing and Judgment Control System for Temperature Maintenance for Optimal Treatment in Hyperthermic Intraperitoneal Chemotherapy Surgery.
Sensors (Basel). 2024 Jan 17;24(2):596. doi: 10.3390/s24020596.
2
Cytoreductive Surgery (CRS) and HIPEC for Advanced Ovarian Cancer with Peritoneal Metastases: Italian PSM Oncoteam Evidence and Study Purposes.
Cancers (Basel). 2022 Dec 6;14(23):6010. doi: 10.3390/cancers14236010.
3
Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Epithelial Ovarian Cancer: A 20-Year Single-Center Experience.
Cancers (Basel). 2021 Jan 29;13(3):523. doi: 10.3390/cancers13030523.
4
Hyperthermic intraperitoneal chemotherapy in ovarian cancer: Qui Bono?
Ann Transl Med. 2020 Dec;8(24):1708. doi: 10.21037/atm-20-1486.
5
CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy.
Sci Adv. 2020 Nov 18;6(47). doi: 10.1126/sciadv.abc9450. Print 2020 Nov.
6
A Retrospective Clinical Analysis of Hyperthermic Intraperitoneal Chemotherapy in Gynecological Cancers: Technical Details, Tolerability, and Efficacy.
Medeni Med J. 2020;35(3):202-211. doi: 10.5222/MMJ.2020.31855. Epub 2020 Sep 30.
7
Current Opinion on Peritoneal Carcinomatosis Treatment: a Survey of the Indian Society of Peritoneal Surface Malignancies (ISPSM).
J Gastrointest Cancer. 2021 Sep;52(3):1061-1066. doi: 10.1007/s12029-020-00538-1. Epub 2020 Oct 19.
8
Evaluation of Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Stage III Epithelial Ovarian Cancer.
JAMA Netw Open. 2020 Aug 3;3(8):e2013940. doi: 10.1001/jamanetworkopen.2020.13940.
9
Plasma-activated Ringer's Lactate Solution Displays a Selective Cytotoxic Effect on Ovarian Cancer Cells.
Cancers (Basel). 2020 Feb 18;12(2):476. doi: 10.3390/cancers12020476.
10
Increased temperature-related adeno-associated virus vectors transduction of ovarian cancer cells - essential signatures of AAV receptor and heat shock proteins.
Exp Ther Med. 2019 Dec;18(6):4718-4732. doi: 10.3892/etm.2019.8112. Epub 2019 Oct 21.
本文引用的文献
1
HIPEC in patients with primary advanced ovarian cancer: Is there a role? A systematic review of short- and long-term outcomes.
Surg Oncol. 2018 Jun;27(2):251-258. doi: 10.1016/j.suronc.2018.05.006. Epub 2018 May 3.
2
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.
N Engl J Med. 2018 Apr 5;378(14):1363-1364. doi: 10.1056/NEJMc1802033.
3
Cancer statistics, 2018.
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
4
OV21/PETROC: a randomized Gynecologic Cancer Intergroup phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer.
Ann Oncol. 2018 Feb 1;29(2):431-438. doi: 10.1093/annonc/mdx754.
5
Cytoreduction (Peritonectomy Procedures) Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Advanced Ovarian Cancer: Retrospective Italian Multicenter Observational Study of 511 Cases.
Ann Surg Oncol. 2017 Apr;24(4):914-922. doi: 10.1245/s10434-016-5686-1. Epub 2016 Nov 28.
6
Long-Term Survival for Platinum-Sensitive Recurrent Ovarian Cancer Patients Treated with Secondary Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
Ann Surg Oncol. 2016 May;23(5):1660-5. doi: 10.1245/s10434-015-5050-x. Epub 2015 Dec 29.
7
Cytoreductive surgery with a hyperthermic intraperitoneal chemotherapy program: Safe after 40 cases, but only controlled after 140 cases.
Eur J Surg Oncol. 2015 Dec;41(12):1671-7. doi: 10.1016/j.ejso.2015.09.005. Epub 2015 Sep 25.
8
Long-term survival advantage and prognostic factors associated with intraperitoneal chemotherapy treatment in advanced ovarian cancer: a gynecologic oncology group study.
J Clin Oncol. 2015 May 1;33(13):1460-6. doi: 10.1200/JCO.2014.55.9898. Epub 2015 Mar 23.
9
Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study.
Ann Surg Oncol. 2015 May;22(5):1570-5. doi: 10.1245/s10434-014-4157-9. Epub 2014 Nov 13.
10
The role of hyperthermic intraperitoneal chemotherapy using paclitaxel in platinum-sensitive recurrent epithelial ovarian cancer patients with microscopic residual disease after cytoreduction.
Ann Surg Oncol. 2015 Mar;22(3):987-93. doi: 10.1245/s10434-014-4049-z. Epub 2014 Sep 12.
Zotero 插件